Terms: = Lung cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954
466 results:
1. Miz1 represses type I interferon production and limits viral clearance during influenza A virus infection.
Wu W; Arunagiri V; Do-Umehara HC; Chen C; Gu S; Biswas I; Ridge KM; Budinger GRS; Liu S; Liu J
Sci Signal; 2024 Apr; 17(831):eadg7867. PubMed ID: 38593156
[TBL] [Abstract] [Full Text] [Related]
2. Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression.
Revel M; Rezola Artero M; Hamidi H; Grunenwald A; Blasco L; Vano YA; Marie Oudard S; Sanchez-Salas R; Macek P; Rodriguez Sanchez L; Cathelineau X; Vedié B; Sautes-Fridman C; Herman Fridman W; Roumenina LT; Dragon-Durey MA
Oncoimmunology; 2024; 13(1):2328433. PubMed ID: 38487624
[TBL] [Abstract] [Full Text] [Related]
3. Metformin and buparlisib synergistically induce apoptosis of non-small lung cancer (NSCLC) cells via Akt/FoxO3a/Puma axis.
Shanshan W; Hongying M; Jingjing F; Rui Y
Toxicol In Vitro; 2024 May; 97():105801. PubMed ID: 38479708
[TBL] [Abstract] [Full Text] [Related]
4. Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell lung cancer Cells by Inhibiting mcl-1 Expression via MET/STAT3/Akt Pathway.
Wang L; Xu L; Han S; Zhu X
Can Respir J; 2024; 2024():2632014. PubMed ID: 38468814
[TBL] [Abstract] [Full Text] [Related]
5. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
Olaleye OO; Kim DH; Spriggs KA
BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
[TBL] [Abstract] [Full Text] [Related]
6. Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas.
Cardillo TM; Zalath MB; Arrojo R; Sharkey RM; Govindan SV; Chang CH; Goldenberg DM
Oncotarget; 2024 Feb; 15():144-158. PubMed ID: 38386805
[TBL] [Abstract] [Full Text] [Related]
7. Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.
Basu A; Winn AN; Johnson KM; Jiao B; Devine B; Hankins JS; Arnold SD; Bender MA; Ramsey SD
Ann Intern Med; 2024 Feb; 177(2):155-164. PubMed ID: 38252942
[TBL] [Abstract] [Full Text] [Related]
8. PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer.
Shin GC; Lee HM; Kim N; Seo SU; Kim KP; Kim KH
Exp Mol Med; 2024 Feb; 56(1):192-209. PubMed ID: 38200153
[TBL] [Abstract] [Full Text] [Related]
9. Acute mast cell leukemia without KIT D816V mutation and lack of CD2 and CD25-a case report of rare entity.
Zaremba-Pataj E; Patkowska E; Krzywdzińska A; Szumera-Ciećkiewicz A; Chlebowska-Tuz J
J Hematop; 2023 Mar; 16(1):39-47. PubMed ID: 38175371
[TBL] [Abstract] [Full Text] [Related]
10. Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
Goto H; Ito S; Kizaki M; Yamaguchi M; Fukuhara N; Kato K; Saito T; Terui Y; Okubo S; Soshin T; Zeng J; Honda H; Badawi M; Ross JA; Izutsu K
Int J Clin Oncol; 2024 Feb; 29(2):232-240. PubMed ID: 38157190
[TBL] [Abstract] [Full Text] [Related]
11. Recurrent and metastatic cellular cutaneous fibrous histiocytoma: A case report and literature review.
Fuentes-Sánchez J; Pena-Burgos EM; Tapia-Viñe M; Ortiz-Cruz EJ; Pozo-Kreilinger JJ
J Cutan Pathol; 2024 Mar; 51(3):214-220. PubMed ID: 38084789
[TBL] [Abstract] [Full Text] [Related]
12. Rate of Pathogenic Germline Variants in Patients With lung cancer.
Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
[TBL] [Abstract] [Full Text] [Related]
13. First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors.
Lakhani NJ; Rasco D; Wang H; Men L; Liang E; Fu T; Collins MC; Min P; Yin Y; Davids MS; Yang D; Zhai Y
Clin Cancer Res; 2024 Feb; 30(3):506-521. PubMed ID: 37971712
[TBL] [Abstract] [Full Text] [Related]
14. Synthesis and Conformational Analysis of FR901464-Based RNA Splicing Modulators and Their Synergism in Drug-Resistant cancers.
Beard JP; Bressin RK; Markaj PL; Schmitz JC; Koide K
J Med Chem; 2023 Nov; 66(21):14497-14512. PubMed ID: 37870431
[TBL] [Abstract] [Full Text] [Related]
15. Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell lung cancer.
Wu T; Yu B; Xu Y; Du Z; Zhang Z; Wang Y; Chen H; Zhang LA; Chen R; Ma F; Gong W; Yu S; Qiu Z; Wu H; Xu X; Wang J; Li Z; Bian J
J Med Chem; 2023 Nov; 66(22):15340-15361. PubMed ID: 37870244
[TBL] [Abstract] [Full Text] [Related]
16. Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia.
Sarkies MN; Testa L; Best S; Moullin JC; Sullivan D; Bishop W; Kostner K; Clifton P; Hare D; Brett T; Hutchinson K; Black A; Braithwaite J; Nicholls SJ; Kangaharan N; Pang J; Abhayaratna W; Horton A; Watts GF
Heart Lung Circ; 2023 Nov; 32(11):1347-1353. PubMed ID: 37865587
[TBL] [Abstract] [Full Text] [Related]
17. The novel small molecule BH3 mimetic nobiletin synergizes with vorinostat to induce apoptosis and autophagy in small cell lung cancer.
Li YQ; Fan F; Wang YR; Li LY; Cao YJ; Gu SM; Liu SS; Zhang Y; Wang J; Tie L; Pan Y; Li HF; Li XJ
Biochem Pharmacol; 2023 Oct; 216():115807. PubMed ID: 37716621
[TBL] [Abstract] [Full Text] [Related]
18. Celastrol impairs tumor growth by modulating the CIP2A-GSK3β-mcl-1 axis in gastric cancer cells.
Wu J; Ye F; Xu T
Aging (Albany NY); 2023 Jul; 15(14):6894-6904. PubMed ID: 37470692
[TBL] [Abstract] [Full Text] [Related]
19. Clinical phenotype and genetic function analysis of a rare family with hereditary leiomyomatosis and renal cell carcinoma complicated with Birt-Hogg-Dubé syndrome.
Pan HH; Ruan DD; Wu M; Chen T; Lu T; Gan YM; Wang C; Liao LS; Lin XF; Chen X; Zhu YB; Fang ZT; Yu QH; Yang GK; Ye LF; Luo JW
J Med Genet; 2023 Nov; 60(12):1210-1214. PubMed ID: 37468236
[TBL] [Abstract] [Full Text] [Related]
20. Myeloid cell leukemia-1 as a candidate prognostic biomarker in cancers: a systematic review and meta-analysis.
Wang J; He Y; Yang C; Luo Q; Wang B
Expert Rev Anticancer Ther; 2023; 23(9):1017-1027. PubMed ID: 37467344
[TBL] [Abstract] [Full Text] [Related]
[Next]
